Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to $17.4 million.

  • Guardian Pharmacy Services' Change in Account Payables rose 51669.62% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year increase of 9746.09%. This contributed to the annual value of $13.2 million for FY2024, which is 11016.68% up from last year.
  • According to the latest figures from Q3 2025, Guardian Pharmacy Services' Change in Account Payables is $17.4 million, which was up 51669.62% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Guardian Pharmacy Services' Change in Account Payables registered a high of $17.4 million during Q3 2025, and its lowest value of -$3.9 million during Q4 2023.
  • In the last 3 years, Guardian Pharmacy Services' Change in Account Payables had a median value of $2.3 million in 2024 and averaged $3.8 million.
  • Over the last 5 years, Guardian Pharmacy Services' Change in Account Payables had its largest YoY gain of 51669.62% in 2025, and its largest YoY loss of 7392.51% in 2025.
  • Guardian Pharmacy Services' Change in Account Payables (Quarter) stood at -$3.9 million in 2023, then surged by 76.31% to -$928000.0 in 2024, then surged by 1974.68% to $17.4 million in 2025.
  • Its last three reported values are $17.4 million in Q3 2025, $1.9 million for Q2 2025, and $1.9 million during Q1 2025.